BioSpace News Archive

Avara Pharmaceutical Services, a world-class contract development and manufacturing organization (CDMO), today announced that it has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of its global footprint.

Enzychem Lifesciences, Corporation (KOSDAQ:18930), a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, today announced the successful completion of a two-day investor roadshow in Singapore and Hong Kong from September 4 to 5, 2018,

Lakeside Community Healthcare (LCH) is working to make flu vaccinations an in-and-out process by offering appointment-free walk-in and drive-thru flu shot clinics in 5 cities throughout Los Angeles and Ventura Counties. Doctors and trained medical staff will be on-site to administer the shots, ensuring a quick and easy experience.

Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Morgan Stanley 2018 Global Health Care Conference on Thursday, September 13, 2018, in New York.

Leading up to hurricane season, top healthcare professionals in Houston developed solutions at the Value Innovation Summit™ to prepare for the greatest challenges of emergency response.

Phase I/II Trial to Investigate Combination Therapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma to take place at Dana-Farber Cancer Institute

Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain (the “Company”), announced today that it will present updated safety and efficacy data of CNTX-4975, the Company’s lead therapeutic candidate, at the 12th Annual PAINWeek National Conference

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) will present initial clinical data for ARO-HBV, the company’s third generation subcutaneously administered RNA interference (RNAi) therapeutic being developed as a potentially curative therapy for patients with chronic hepatitis B virus (HBV) infection,

Second year medical students with an established track record of community leadership, superior communication skills and demonstrated interest in advancing knowledge are recognized today with the Canadian Medical Hall of Fame (CMHF) Award

Bloom Science and Biose industrie announced today an agreement for the manufacture development of Bloom Science’s novel epilepsy Live Biotherapeutic Product (LBP).